Predicting the Long-Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN-1 Trial
Diabetes, Obesity & Metabolism
The paper
Shraddha Shinde, Florian Kahles, Simona Z Vasileva-Metodiev, Jens Aberle
Show 7 more authors
Ryan M. Griffin, Hong Liu‐Seifert, Jeremie Lebrec, Neena A. Xavier, Runjia Li, Suzanne R. Klise, Ambrish Singh,Eli Lilly (United States) · University Medical Center Hamburg-Eppendorf
Diabetes, Obesity & Metabolism · 17 Sep 2026